Psoriasis-Ltd III is not a cream, a lotion, a spray or even a pill. Treatment options for psoriasis have come a long way. A team of Psoriasis Treatment Researchers with 32 years of combined
research experience developed Psoriasis-Ltd. Psoriasis-Ltd was first
marketed in 2001, and its parent company, Bass & Boney, Inc.
has been in business since 1983. Psoriasis-Ltd has medical patents
throughout the world.
Research indicates that up to 10% of psoriasis sufferers may experience ocular symptoms. It is rare to have symptoms of ocular involvement prior to skin involvement of psoriasis. Ocular psoriasis treatment is aimed at preventing irritation and controlling inflammation.
<< Home